TNFSF11 and osteogenesis imperfecta: Other new potential therapies for OI, such as mesenchymal stem cells, anti-RANKL antibodies, sclerostin inhibitory antibodies, recombinant human parathormone, TGF beta inhibition, and gene therapy, showed promising results in vitro and in vivo in animal models or human practice, but they need to be researched furthermore.